Bio-Rad Laboratories, Inc. (BIO)

NYSE: BIO · Real-Time Price · USD

388.64

-1.70 (-0.44%)

At close: Aug 26, 2026, 4:00 PM EDT

388.64

0.00 (0.00%)

After-hours: Aug 26, 2026, 4:10 PM EDT

Bio-Rad Laboratories Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,589	2,583	2,567	2,671	2,802	2,923
Revenue Growth	1.37%	0.65%	-3.92%	-4.67%	-4.12%	14.81%
Gross Profit	1,348	1,344	1,394	1,431	1,567	1,663
Operating Income	272.3	266.2	289.2	365.7	482.6	564.74
Net Income	222.4	759.9	-1,844	-637.3	-3,628	4,254
Earnings Per Share	8.26	27.85	-65.36	-21.82	-121.79	140.83
EPS Growth	-28.17%	-	-	-	-	11.35%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Life Science	1,010	1,021	1,028	1,178	1,347	1,401
Clinical Diagnostics	1,579	1,562	1,538	1,489	1,451	1,516
Other Segments	-	-	0.5	3.5	4	5.8
Revenue (Total)	2,589	2,583	2,567	2,671	2,802	2,923

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,619	1,541	1,665	1,607	1,791	869.92
Total Debt	1,370	1,385	1,375	1,406	1,388	223.38
Net Cash (Debt)	248.1	155.9	289.8	201.6	402.56	646.54
Net Cash Growth	-	-46.20%	43.75%	-49.92%	-37.74%	-15.53%
Net Cash Per Share	9.22	5.71	10.27	6.90	13.52	21.40

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	492.6	532.2	455.2	374.9	194.4	669.5
Capital Expenditures	-139.5	-157.6	-165.6	-156.7	-112.8	-133.75
Free Cash Flow	353.1	374.6	289.6	218.2	81.6	535.75
Free Cash Flow Growth	-4.83%	29.35%	32.72%	167.40%	-84.77%	12.45%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	52.04%	52.01%	54.30%	53.56%	55.93%	56.91%
Operating Margin	10.52%	10.30%	11.27%	13.69%	17.22%	19.32%
Pretax Margin	13.53%	38.54%	-91.27%	-31.82%	-167.88%	186.45%
Profit Margin	8.59%	29.42%	-71.86%	-23.86%	-129.45%	145.57%
FCF Margin	13.64%	14.50%	11.28%	8.17%	2.91%	18.33%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	47.08	10.81	-	-	-	5.28
Forward PE	37.72	28.94	28.85	26.51	28.66	59.87
P/FCF Ratio	29.41	21.92	31.71	43.08	152.70	41.88
PS Ratio	4.01	3.18	3.58	3.52	4.45	7.68